Literature DB >> 19587342

Clinical practice. Screening for ovarian cancer.

Daniel L Clarke-Pearson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19587342     DOI： 10.1056/NEJMcp0901926

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  118 in total

Review 1.  Protein biomarkers of ovarian cancer: the forest and the trees.

Authors:  Brian M Nolen; Anna E Lokshin
Journal:  Future Oncol       Date:  2012-01       Impact factor: 3.404

2.  Preclinical evaluation of Mab CC188 for ovarian cancer imaging.

Authors:  M Xu; M P Rettig; G Sudlow; B Wang; W J Akers; D Cao; D G Mutch; J F DiPersio; S Achilefu
Journal:  Int J Cancer       Date:  2012-01-11       Impact factor: 7.396

3.  Bowel obstruction and pelvic mass.

Authors:  Ally Murji; Mara L Sobel
Journal:  CMAJ       Date:  2010-12-13       Impact factor: 8.262

4.  Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation.

Authors:  Tzu-Hao Wang; Angel Chao; Chia-Lung Tsai; Chih-Long Chang; Shun-Hua Chen; Yun-Shien Lee; Jen-Kun Chen; Yi-Jun Lin; Pi-Yueh Chang; Chin-Jung Wang; An-Shine Chao; Shuenn-Dyh Chang; Ting-Chang Chang; Chyong-Huey Lai; Hsin-Shih Wang
Journal:  Mol Cell Proteomics       Date:  2010-05-25       Impact factor: 5.911

5.  A survey of the practice patterns of gynecologic oncologists dealing with hereditary cancer patients in Japan.

Authors:  Noriko Tanabe; Ayumi Shikama; Hiroko Bando; Toyomi Satoh; Chikako Shimizu
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

6.  Integration of cell phone imaging with microchip ELISA to detect ovarian cancer HE4 biomarker in urine at the point-of-care.

Authors:  Shuqi Wang; Xiaohu Zhao; Imran Khimji; Ragip Akbas; Weiliang Qiu; Dale Edwards; Daniel W Cramer; Bin Ye; Utkan Demirci
Journal:  Lab Chip       Date:  2011-09-01       Impact factor: 6.799

7.  Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT/Cyclin D1/CDK4 pathway in vitro and in vivo.

Authors:  Meng Gao; Yanyan Ma; Robert C Bast; Yue Li; Lu Wan; Yanping Liu; Yingshuo Sun; Zhenghui Fang; Lining Zhang; Xiaoyan Wang; Zengtao Wei
Journal:  Med Oncol       Date:  2016-06-08       Impact factor: 3.064

Review 8.  Translational application of epigenetic alterations: ovarian cancer as a model.

Authors:  Marie E Maradeo; Paul Cairns
Journal:  FEBS Lett       Date:  2011-03-12       Impact factor: 4.124

9.  Major clinical research advances in gynecologic cancer in 2010.

Authors:  Dong Hoon Suh; Jae Weon Kim; Kidong Kim; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2010-12-31       Impact factor: 4.401

10.  Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis.

Authors:  Karen L Abbott; Jae-Min Lim; Lance Wells; Benedict B Benigno; John F McDonald; Michael Pierce
Journal:  Proteomics       Date:  2010-02       Impact factor: 3.984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.